Cao, H., Li, J., Wang, L., Liu, J., Li, B., Li, Q. (2026). Tislelizumab in combination with carboplatin and albumin–binding paclitaxel for neoadjuvant therapy in head and neck squamous cell carcinoma: A prospective, phase II clinical study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.19_suppl.226